108 related articles for article (PubMed ID: 2783154)
1. Selective delivery of drugs to macrophages through a highly specific receptor. An efficient chemotherapeutic approach against leishmaniasis.
Chaudhuri G; Mukhopadhyay A; Basu SK
Biochem Pharmacol; 1989 Sep; 38(18):2995-3002. PubMed ID: 2783154
[TBL] [Abstract][Full Text] [Related]
2. Enhanced intracellular delivery of methotrexate by a receptor-mediated process.
Mukhopadhyay A; Basu SK
Biotechnol Appl Biochem; 1990 Oct; 12(5):529-36. PubMed ID: 2288708
[TBL] [Abstract][Full Text] [Related]
3. Receptor-mediated drug delivery to macrophages in chemotherapy of leishmaniasis.
Mukhopadhyay A; Chaudhuri G; Arora SK; Sehgal S; Basu SK
Science; 1989 May; 244(4905):705-7. PubMed ID: 2717947
[TBL] [Abstract][Full Text] [Related]
4. Sugar receptor mediated drug delivery to macrophages in the therapy of experimental visceral leishmaniasis.
Chakraborty P; Bhaduri AN; Das PK
Biochem Biophys Res Commun; 1990 Jan; 166(1):404-10. PubMed ID: 2302213
[TBL] [Abstract][Full Text] [Related]
5. Neoglycoproteins as carriers for receptor-mediated drug targeting in the treatment of experimental visceral leishmaniasis.
Chakraborty P; Bhaduri AN; Das PK
J Protozool; 1990; 37(5):358-64. PubMed ID: 2213650
[TBL] [Abstract][Full Text] [Related]
6. Killing of intracellular Mycobacterium tuberculosis by receptor-mediated drug delivery.
Majumdar S; Basu SK
Antimicrob Agents Chemother; 1991 Jan; 35(1):135-40. PubMed ID: 1901694
[TBL] [Abstract][Full Text] [Related]
7. Scavenger receptor-mediated delivery of antisense mini-exon phosphorothioate oligonucleotide to Leishmania-infected macrophages. Selective and efficient elimination of the parasite.
Chaudhuri G
Biochem Pharmacol; 1997 Feb; 53(3):385-91. PubMed ID: 9065742
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed Macrophage Mannose Receptor Targeted Nanocapsules- Mediated Cargo Delivery Approach for Eradication of Resident Parasite: In Vitro and In Vivo Studies.
Asthana S; Gupta PK; Jaiswal AK; Dube A; Chourasia MK
Pharm Res; 2015 Aug; 32(8):2663-77. PubMed ID: 25715698
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-directed delivery of doxorubicin conjugated to neoglycoprotein using leishmaniasis as the model disease.
Sett R; Sarkar K; Das PK
J Infect Dis; 1993 Oct; 168(4):994-9. PubMed ID: 8376846
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate conjugate with branched polypeptide influences Leishmania donovani infection in vitro and in experimental animals.
Kóczán G; Ghose AC; Mookerjee A; Hudecz F
Bioconjug Chem; 2002; 13(3):518-24. PubMed ID: 12009941
[TBL] [Abstract][Full Text] [Related]
11. Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis.
Kansal S; Tandon R; Dwivedi P; Misra P; Verma PR; Dube A; Mishra PR
J Antimicrob Chemother; 2012 Nov; 67(11):2650-60. PubMed ID: 22872448
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of tumouricidal activity of daunomycin by receptor-mediated delivery. In vivo studies.
Mukhopadhyay B; Mukhopadhyay A; Basu SK
Biochem Pharmacol; 1993 Sep; 46(5):919-24. PubMed ID: 8373443
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic and therapeutic activity of alkaline phosphatase in arthritic rats: single-agent effects of alkaline phosphatase and synergistic effects in combination with methotrexate.
Chandrupatla DMSH; Molthoff CFM; Ritsema WIGR; Vos R; Elshof E; Matsuyama T; Low PS; Musters RJP; Hammond A; Windhorst AD; Lammertsma AA; van der Laken CJ; Brands R; Jansen G
Transl Res; 2018 Sep; 199():24-38. PubMed ID: 29802817
[TBL] [Abstract][Full Text] [Related]
14. Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.
Taylor VM; Muñoz DL; Cedeño DL; Vélez ID; Jones MA; Robledo SM
Exp Parasitol; 2010 Dec; 126(4):471-5. PubMed ID: 20685203
[TBL] [Abstract][Full Text] [Related]
15. Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine.
Tempone AG; Perez D; Rath S; Vilarinho AL; Mortara RA; de Andrade HF
J Antimicrob Chemother; 2004 Jul; 54(1):60-8. PubMed ID: 15163652
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic evaluation of free and liposome-loaded furazolidone in experimental visceral leishmaniasis.
Tempone AG; Mortara RA; de Andrade HF; Reimão JQ
Int J Antimicrob Agents; 2010 Aug; 36(2):159-63. PubMed ID: 20554161
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate transport mechanisms: the basis for targeted drug delivery and ß-folate-receptor-specific treatment.
Fiehn C
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S40-5. PubMed ID: 21044432
[TBL] [Abstract][Full Text] [Related]
19. An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani.
Neal RA; Croft SL
J Antimicrob Chemother; 1984 Nov; 14(5):463-75. PubMed ID: 6096347
[TBL] [Abstract][Full Text] [Related]
20. Characterization of in-vitro drug release and biological activity of methotrexate-bovine serum albumin conjugates.
Halbert GW; Florence AT; Stuart JF
J Pharm Pharmacol; 1987 Nov; 39(11):871-6. PubMed ID: 2892908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
